Ledger.Open graph →
SEC Form D · filed August 9, 2016

Providence Therapeutics Inc

Offering
$1.5M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Bradley T. Sorenson · Calgary, Alberta, CanadaExec · DirectorEric G. Marcusson · San Francisco, CAExecJohn B. Collis · Boston, MAExec · DirectorNicholas M. Dean · Encinitas, CAExec · DirectorRichard W. Scarinci · Boston, MAExec · DirectorEric G. Marcusson · San Francisco, CAExecNicholas M. Dean · Encinitas, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗